Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

A large new study suggests they may drastically reduce the risk substance use disorders and drug-related deaths.

I don’t drink anymore. I don’t smoke anymore.” He might have shrugged it off, but reports accumulated in his clinic and ...

Weight-loss jabs could prevent and treat addiction to alcohol, cigarettes and drugs, according to a large study. Experts believe the way the medicines work on the brain’s reward pathway cuts cravings ...

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

A study of 600,000+ veterans found GLP-1 drugs like Ozempic reduced substance-related deaths by 50% across alcohol, opioids, cocaine, nicotine, and cannabis — making them the first medication class to ...

Researchers identify the anterior insula as the brain region responsible for biasing decisions toward alcohol over social rewards in addiction.

Weight loss drugs catapulted many into a new wellness era, and gave hope to those with diabetes, obesity and who struggled to lose weight. The global anti-obesity drugs market — including the more ...

GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...

Her blood alcohol concentration was 0.416%, more than five times the legal intoxication limit in the U.S. – leading her cause of death to be later adjusted to include "alcohol toxicity" following a ...

Researchers at Virginia Commonwealth University have found fecal transplants may be helpful in reducing drinking behaviors in those suffering severe alcohol use disorder (AUD). The work points to a ...